| Key for crossing the BBB with nanoparticles: The rational design SM Lombardo, M Schneider, AE Türeli, NG Türeli Beilstein journal of nanotechnology 11 (1), 866-883, 2020 | 142 | 2020 |
| Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections NG Türeli, A Torge, J Juntke, BC Schwarz, N Schneider-Daum, AE Türeli, ... European Journal of Pharmaceutics and Biopharmaceutics 117, 363-371, 2017 | 125 | 2017 |
| The solid progress of nanomedicine JP Martins, J Das Neves, M de la Fuente, C Celia, H Florindo, ... Drug delivery and translational research 10, 726-729, 2020 | 116 | 2020 |
| Ciprofloxacin-loaded polymeric nanoparticles incorporated electrospun fibers for drug delivery in tissue engineering applications C Guenday, S Anand, HB Gencer, S Munafo, L Moroni, A Fusco, ... Drug Delivery and Translational Research 10, 706-720, 2020 | 78 | 2020 |
| Development, standardization and testing of a bacterial wound infection model based on ex vivo human skin C Schaudinn, C Dittmann, J Jurisch, M Laue, N Günday-Türeli, ... PLoS One 12 (11), e0186946, 2017 | 49 | 2017 |
| Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach NG Türeli, AE Türeli, M Schneider International journal of pharmaceutics 515 (1-2), 343-351, 2016 | 48 | 2016 |
| Evaluation of potential environmental toxicity of polymeric nanomaterials and surfactants I Hering, E Eilebrecht, MJ Parnham, N Günday-Türeli, AE Türeli, M Weiler, ... Environmental toxicology and pharmacology 76, 103353, 2020 | 33 | 2020 |
| Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond NG Türeli, AE Türeli, M Schneider International journal of pharmaceutics 511 (2), 994-1001, 2016 | 24 | 2016 |
| Testing of aerosolized ciprofloxacin nanocarriers on cystic fibrosis airway cells infected with P. aeruginosa biofilms J Juntke, X Murgia, N Günday Türeli, AE Türeli, CR Thorn, M Schneider, ... Drug delivery and translational research 11 (4), 1752-1765, 2021 | 21 | 2021 |
| Nano-in-micro-particles consisting of PLGA nanoparticles embedded in chitosan microparticles via spray-drying enhances their uptake in the olfactory mucosa LM Spindler, A Feuerhake, S Ladel, C Günday, J Flamm, N Günday-Türeli, ... Frontiers in Pharmacology 12, 732954, 2021 | 19 | 2021 |
| Preparation of fenofibrate loaded eudragit l100 nanoparticles by nanoprecipitation method G Torres-Flores, GT Nazende, TA Emre Materials Today: Proceedings 13, 428-435, 2019 | 17 | 2019 |
| Reliable release testing for nanoparticles with the NanoDis System, an innovative sample and separate technique SM Lombardo, NG Türeli, M Koch, M Schneider, AE Türeli International Journal of Pharmaceutics 609, 121215, 2021 | 16 | 2021 |
| Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug products F Jung, M Thurn, K Krollik, GF Gao, I Hering, E Eilebrecht, Y Emara, ... Environmental Research 192, 110219, 2021 | 16 | 2021 |
| Influence of different stabilizers on the encapsulation of desmopressin acetate into PLGA nanoparticles D Primavessy, NG Türeli, M Schneider European Journal of Pharmaceutics and Biopharmaceutics 118, 48-55, 2017 | 13 | 2017 |
| Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells ELJ Moya, SM Lombardo, E Vandenhaute, M Schneider, C Mysiorek, ... International journal of pharmaceutics 621, 121780, 2022 | 8 | 2022 |
| Drug Delivery Transl JP Martins, J das Neves, M de la Fuente, C Celia, H Florindo, ... Res 10, 726-729, 2020 | 8 | 2020 |
| Good manufacturing practices (GMP) of magnetic nanoparticles NG Türeli, AE Türeli Clinical applications of magnetic nanoparticles, 475-484, 2018 | 8 | 2018 |
| Screening of Surfactants for Improved Delivery of Antimicrobials and Poly-Lactic-co-Glycolic Acid Particles in Wound Tissue F Rancan, J Jurisch, C Günday, E Türeli, U Blume-Peytavi, A Vogt, ... Pharmaceutics 13 (7), 1093, 2021 | 7 | 2021 |
| Upscaling and GMP production of pharmaceutical drug delivery systems NG Türeli, AE Türeli Drug Delivery Trends, 215-229, 2020 | 7 | 2020 |
| Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues Ž Debeljak, IV Vrček, N Drinković, V Micek, E Galić, D Gorup, M Ćurlin, ... Analyst 147 (14), 3201-3208, 2022 | 4 | 2022 |
Marc SchneiderProfessor for Biopharmaceutics and Pharmaceutical Technology, Saarland UniversityDirección de correo verificada de mx.uni-saarland.de
